The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Randomized, Placebo-Controlled Trial of the Effects of Donepezil on Neuronal Markers and Hippocampal Volumes in Alzheimer’s Disease
Abstract
OBJECTIVE: The authors examined the effect of the acetylcholinesterase inhibitor donepezil on magnetic resonance markers of neurodegeneration in Alzheimer's disease. METHOD: In this randomized, double-blind, placebo-controlled pilot study, 67 patients with mild to moderate Alzheimer's disease received 24 weeks of treatment with donepezil (5 mg/day for the first 28 days and 10 mg/day thereafter) or placebo. Patients were reevaluated at 6-week intervals to measure change from baseline in several outcome measures, including right, left, and total hippocampal volumes, measured with magnetic resonance imaging; brain concentrations of N-acetylaspartate, measured with proton magnetic resonance spectroscopy; and cognition, assessed with the Alzheimer's Disease Assessment Scale cognitive subscale. RESULTS: At some interim assessments, mean normalized measures of N-acetylaspartate concentration tended to be higher in the donepezil-treated patients than in the patients who received placebo, but these differences were not significant at endpoint. At endpoint, the donepezil-treated patients had significantly smaller mean decreases in total and right hippocampal volumes and a smaller, nearly significant mean decrease in left hippocampal volume, compared with the placebo-treated patients. Mean Alzheimer's Disease Assessment Scale cognitive subscale scores were improved after treatment with donepezil, relative to placebo, at weeks 6, 12, 18, and 24. CONCLUSIONS: These preliminary results suggest that donepezil may have a potentially protective effect in Alzheimer's disease. Larger, longer-term confirmatory studies of the medication's effects are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
. Cerebral blood flow in dementia.
Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., McAllister, V. L., Marshall, J., Russell, R. W. R., & Symon, L. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510088009 · Cited by 3,186
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R., Friedhoff, L. T., & Donepezil Study Group* (1998) · Neurology · doi:10.1212/wnl.50.1.136 · Cited by 1,618
Self-citationSilverman, D. H. S., Small, G. W., Chang, C. Y., Lu, C. S., de Aburto, M. A. K., Chen, W., Czernin, J., Rapoport, S. I., Pietrini, P., Alexander, G. E., et al. (2001) · JAMA · doi:10.1001/jama.286.17.2120 · Cited by 951
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD
Jack, C. R., Petersen, R. C., Xu, Y., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Tangalos, E. G., & Kokmen, E. (2000) · Neurology · doi:10.1212/wnl.55.4.484 · Cited by 937
Rogers, S. L. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.9.1021 · Cited by 773
Self-citationScahill, R. I., Schott, J. M., Stevens, J. M., Rossor, M. N., & Fox, N. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052587399 · Cited by 764
Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia
Jack, C. R., Dickson, D. W., Parisi, J. E., Xu, Y. C., Cha, R. H., O’Brien, P. C., Edland, S. D., Smith, G. E., Boeve, B. F., Tangalos, E. G., et al. (2002) · Neurology · doi:10.1212/wnl.58.5.750 · Cited by 610
Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing’s disease
Starkman, M. N., Giordani, B., Gebarski, S. S., Berent, S., Schork, M. A., & Schteingart, D. E. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00203-6 · Cited by 455
Cummings, J. L. (2002) · JAMA · doi:10.1001/jama.287.18.2335 · Cited by 439
Reversible decreases in N‐acetylaspartate after acute brain injury
Stefano, N. D., Matthews, P. M., & Arnold, D. L. (1995) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910340511 · Cited by 438
Treatment of Alzheimer's Disease
Mayeux, R., & Sano, M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911253412207 · Cited by 385
Baslow, M. H. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750453.x · Cited by 240
Demougeot, C., Garnier, P., Mossiat, C., Bertrand, N., Giroud, M., Beley, A., & Marie, C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00285.x · Cited by 194
Small, D. H., Michaelson, S., & Sberna, G. (1996) · Neurochemistry International · doi:10.1016/0197-0186(95)00099-2 · Cited by 188
Neuronal Apoptosis Induced by β-Amyloid Is Mediated by Caspase-8
Ivins, K. J., Thornton, P. L., Rohn, T. T., & Cotman, C. W. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0268 · Cited by 188
Total brain N -acetylaspartate: A new measure of disease load in MS
Gonen, O., Catalaa, I., Babb, J. S., Ge, Y., Mannon, L. J., Kolson, D. L., & Grossman, R. I. (2000) · Neurology · doi:10.1212/wnl.54.1.15 · Cited by 181
Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease
Adalsteinsson, E., Sullivan, E., Kleinhans, N., Spielman, D., & Pfefferbaum, A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02246-7 · Cited by 174
Dautry, C., Vaufrey, F., Brouillet, E., Bizat, N., Henry, P., Condé, F., Bloch, G., & Hantraye, P. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200005000-00005 · Cited by 146
Parnetti, L., Lowenthal, D. T., Presciutti, O., Pelliccioli, G., Palumbo, R., Gobbi, G., Chiarini, P., Palumbo, B., Tarducci, R., & Senin, U. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb02428.x · Cited by 128
Hippocampal Volume and Incident Dementia in Geriatric Depression
Steffens, D. C., Payne, M. E., Greenberg, D. L., Byrum, C. E., Welsh-Bohmer, K. A., Wagner, H. R., & MacFall, J. R. (2002) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200201000-00008 · Cited by 128
Vion‐Dury, J., Nicoli, F., Salvan, A.-M., Sylviane Confort-gouny, A., Dhiver, C., & Cozzone, P. J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91184-7 · Cited by 116
Tacrine and donepezil attenuate the neurotoxic effect of Aβ(25-35) in rat PC12 cells
Svensson, A., & Nordberg, A. K. (1998) · Neuroreport · doi:10.1097/00001756-199805110-00050 · Cited by 100
Decrease of N -acetylaspartate in the MTL correlates with cognitive decline of AD patients
Jessen, F., Block, W., Träber, F., Keller, E., Flacke, S., Lamerichs, R. M. J. N., Schild, H. H., & Heun, R. (2001) · Neurology · doi:10.1212/wnl.57.5.930 · Cited by 94
Filippi, M., Dousset, V., McFarland, H. F., Miller, D. H., & Grossman, R. I. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10097 · Cited by 76
Decrease and Recovery of N -Acetylaspartate/Creatine in Rat Brain Remote from Focal Injury
Gasparovic, C., Arfai, N., Smid, N. H., & Feeney, D. M. (2001) · Journal of Neurotrauma · doi:10.1089/08977150151070856 · Cited by 63
An in vitro 1H nuclear magnetic resonance study of the temporoparietal cortex of Alzheimer brains
Mohanakrishnan, P., Fowler, A. H., Vonsattel, J. P., Husain, M. M., Jolles, P. R., Liem, P. H., & Komoroski, R. A. (1995) · Experimental Brain Research · doi:10.1007/bf00230654 · Cited by 62
Treatment for Alzheimer's Disease?
Growdon, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271810 · Cited by 57
Multisite validation of image analysis methods: assessing intra- and intersite variability
Styner, M. A., Charles, H. C., Park, J. K., & Gerig, G. (2002) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.467167 · Cited by 55
Self-citationMetabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy.
Lazeyras, F., Charles, H., Tupler, L., Erickson, R., Boyko, O., & Krishnan, K. (1998) · Psychiatry Research · doi:10.1016/s0925-4927(98)00010-9 · Cited by 52
Self-citationA repeat proton magnetic resonance spectroscopy study in social phobia
Tupler, L. A., Davidson, J. R. T., Smith, R. D., Lazeyras, F., Charles, H. C., & Krishnan, K. R. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00501-x · Cited by 50
Self-citationDefining Meaningful Change in Alzheimer's Disease Trials: The Donepezil Experience
McLendon, B. M., & Doraiswamy, P. M. (1999) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879901200108 · Cited by 37
Self-citationBrain Magnetic Resonance Spectroscopy
Doraiswamy, P. M., Chen, J. G., & Charles, H. C. (2000) · CNS Drugs · doi:10.2165/00023210-200014060-00004 · Cited by 30
Self-citationCurrent and future treatments for cognitive deficits in dementia
McLendon, B. M., Chen, G. G., & Doraiswamy, P. M. (2000) · Current Psychiatry Reports · doi:10.1007/s11920-000-0037-z · Cited by 4
Self-citation
Cited by
The clinical use of structural MRI in Alzheimer disease
Frisoni, G. B., Fox, N. C., Jack, C. R., Scheltens, P., & Thompson, P. M. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.215 · Cited by 2,113
Cholinesterase inhibitors for Alzheimer's disease
Birks, J. S. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005593 · Cited by 1,906
Donepezil for dementia due to Alzheimer’s disease.
Birks, J. S., & Harvey, R. J. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001190.pub3 · Cited by 1,200
Raina, P., Santaguida, P., Ismaila, A., Patterson, C., Cowan, D., Levine, M., Booker, L., & Oremus, M. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-5-200803040-00009 · Cited by 771
Clinical Proton MR Spectroscopy in Central Nervous System Disorders
Öz, G., Alger, J. R., Barker, P. B., Bartha, R., Bizzi, A., Boesch, C., Bolan, P. J., Brindle, K. M., Cudalbu, C., Dinçer, A., et al. (2014) · Radiology · doi:10.1148/radiol.13130531 · Cited by 660
Metadata
- Authors
- Krishnan, K. R. R., Charles, H. C., Doraiswamy, P. M., Mintzer, J., Weisler, R., Yu, X., Perdomo, C., Ieni, J. R., & Rogers, S.
- Venue
- American Journal of Psychiatry
- Published
- 2003-11-01
- Volume
- 160
- Issue
- 11
- Pages
- 2003-2011
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2110287843
- Cited by
- 282
- References
- 37
- FWCI
- 11.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.